Equities

Oxford Biodynamics PLC

OBD:LSE

Oxford Biodynamics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.280
  • Today's Change-0.02 / -6.67%
  • Shares traded19.11m
  • 1 Year change-46.67%
  • Beta2.8692
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Sep 30 2025202520242023
OPERATIONS
Net income(11)(12)(11)
Depreciation/depletion1.051.301.21
Non-Cash items1.240.511.62
Cash taxes paid, supplemental(0.44)(0.68)(0.9)
Cash interest paid, supplemental0.190.230.21
Changes in working capital1.41(0.2)0.14
Total cash from operations(7.57)(10)(8.29)
INVESTING
Capital expenditures(0.24)(0.6)(0.72)
Other investing and cash flow items, total1.06(0.89)0.10
Total cash from investing0.81(1.49)(0.62)
FINANCING
Financing cash flow items(0.46)(0.98)(1.46)
Total cash dividends paid------
Issuance (retirement) of stock, net7.449.8615
Issuance (retirement) of debt, net(0.66)(0.62)(0.72)
Total cash from financing6.338.2513
NET CHANGE IN CASH
Foreign exchange effects0(0.02)(0.02)
Net change in cash(0.44)(3.42)4.28
Net cash-begin balance/reserved for future use1.835.250.97
Net cash-end balance/reserved for future use1.391.835.25
SUPPLEMENTAL INCOME
Depreciation, supplemental1.051.301.21
Cash interest paid, supplemental0.190.230.21
Cash taxes paid, supplemental(0.44)(0.68)(0.9)
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.